China’s antitrust regulator has indefinitely postponed approval of a landmark $35 billion merger between American software giants Synopsys and Ansys, dealing a significant blow to what would be one of the largest technology deals of 2025.
The delay comes as a direct response to the Trump administration’s latest round of semiconductor export restrictions targeting Chinese companies, underscoring how regulatory approval processes have become weaponized in the escalating U.S.-China trade war.
The postponement by China’s State Administration for Market Regulation (SAMR) follows President Trump’s recent tightening of chip export controls, which specifically targeted semiconductor design software—the very products that form the core of both companies’ business models.
The timing appears deliberate: the merger had reached the final stages of Chinese regulatory review and was expected to receive approval by month’s end.
A Deal Nearly Two Years in the Making
The proposed acquisition, announced in early 2024, would create a semiconductor design software behemoth combining Synopsys’s electronic design automation tools with Ansys’s simulation and analysis capabilities. Together, the companies provide the critical software infrastructure that enables the design of everything from smartphone processors to artificial intelligence chips.
Despite the Chinese delay, Synopsys has maintained it remains on track to complete the acquisition by the end of June, though this timeline now appears increasingly optimistic given Beijing’s apparent unwillingness to cooperate. The company has secured regulatory clearances in all other major jurisdictions, including recent approval from the European Commission and conditional clearance from the U.S. Federal Trade Commission.
Export Controls Drive Regulatory Retaliation
The Chinese delay represents a textbook example of regulatory tit-for-tat in the modern trade war. Washington’s decision in late May to ban U.S. chip design software sales to China, including products from Synopsys, prompted Beijing to reconsider its approval of the merger. The move effectively demonstrates China’s ability to hold American corporate interests hostage in response to U.S. trade restrictions.
The broader context involves a tentative trade truce reached between U.S. and Chinese officials during talks in London this week, though previous agreements have proven fragile. The Trump administration has simultaneously expanded export controls to include jet engines for Chinese-manufactured aircraft and other strategic goods, signaling a comprehensive approach to technology transfer restrictions.
Strategic Implications for Global Tech
For the semiconductor industry, the delayed merger highlights the growing fragmentation of global technology markets along geopolitical lines. Both Synopsys and Ansys provide essential tools for chip design that Chinese companies have historically relied upon. The export restrictions force Chinese firms to develop domestic alternatives or seek software from third-party suppliers, potentially accelerating China’s push for technological self-sufficiency.
The situation also illustrates the vulnerabilities facing multinational corporations caught between competing superpowers. Major technology deals now face the risk of becoming collateral damage in broader diplomatic disputes, adding significant uncertainty to merger and acquisition activity in the sector.
Market Response and Future Outlook
Neither Synopsys nor Ansys has provided an official comment on the Chinese delay, maintaining their standard practice of not discussing ongoing regulatory processes. However, the companies’ ability to complete the transaction by their stated timeline now depends entirely on Beijing’s willingness to depoliticize the approval process.
The delay sends a clear signal that China retains significant leverage over American technology companies despite U.S. export restrictions. As both nations continue to weaponize regulatory processes, multinational corporations may increasingly find themselves forced to choose between market access and compliance with home country restrictions—a dilemma that could reshape global technology partnerships for years to come.
The ultimate resolution of this merger will likely serve as a bellwether for future U.S.-China technology cooperation, with implications extending far beyond the immediate parties involved.
WHAT YOU SHOULD KNOW
China is blocking a major $35 billion U.S. software merger as retaliation for Trump’s chip export restrictions, turning corporate deals into weapons in the trade war.
China’s delay of the Synopsys-Ansys merger approval, which was nearly finalized, directly responds to Washington’s ban on semiconductor design software sales to China.
This demonstrates how both superpowers now weaponize regulatory processes against each other’s companies, making multinational corporations collateral damage in geopolitical disputes.
The tech industry faces a new reality where major business deals can be held hostage by diplomatic tensions, forcing companies to navigate between market access and home country compliance requirements.
